NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.04% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.81% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.72% |
| UMRX | Cogent Biosciences Inc | Healthcare | Biotechnology | 3.37% |
| UCB | UCB SA | Healthcare | Biotechnology | 3.33% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.18% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 3.03% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.76% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.64% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.58% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.49% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.46% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.39% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.33% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 2.29% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.26% |
| HTFL | Heartflow, Inc. Common Stock | Healthcare | Health Information Services | 2.22% |
| CAI | Caris Life Sciences, Inc. Common Stock | Healthcare | Biotechnology | 2.15% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.98% |
| PRVA | Privia Health Group Inc | Healthcare | Health Information Services | 1.94% |